Active	Status	Sponsor type	Region	Phase	Filter
15 Active 26 Inactive 41 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Park, Ji Yeon
NCT05573815: Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images	Recruiting	N/A	558	RoW	BT-M01	Heuron Inc.	Brain Metastases	11/22	12/22
NCT05716672: Impact of Lazertinib Dose Modification on Effectiveness and Safety	Not yet recruiting	N/A	200	RoW	Lazertinib, LECLAZA	Pusan National University Hospital, Yuhan Corporation	Non-small Cell Lung Cancer	12/25	12/25
Cho, Jung Won
ERTEMIS, NCT05540587: Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis	Recruiting	2	240	RoW	Edoxaban, Warfarin	Sung-Hwan Kim, Daiichi Sankyo Korea Co., Ltd.	Mitral Valve Stenosis, Atrial Fibrillation, Stroke, Systemic Embolism	05/24	05/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Park, Ji Yeon
NCT05573815: Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images	Recruiting	N/A	558	RoW	BT-M01	Heuron Inc.	Brain Metastases	11/22	12/22
NCT05716672: Impact of Lazertinib Dose Modification on Effectiveness and Safety	Not yet recruiting	N/A	200	RoW	Lazertinib, LECLAZA	Pusan National University Hospital, Yuhan Corporation	Non-small Cell Lung Cancer	12/25	12/25
Cho, Jung Won
ERTEMIS, NCT05540587: Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis	Recruiting	2	240	RoW	Edoxaban, Warfarin	Sung-Hwan Kim, Daiichi Sankyo Korea Co., Ltd.	Mitral Valve Stenosis, Atrial Fibrillation, Stroke, Systemic Embolism	05/24	05/26